VBI Vaccines is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. VBI’s innovative approach to vaccine development and growing pipeline of vaccine programs address significant market opportunities and are designed to answer critical unmet medical needs. Through a recent strategic acquisition, VBI has expanded its pipeline of thermostable vaccine programs and is also developing its own VLP-based vaccines.

Read more